Physician profile
David N Westerdahl
NPI 1356305023
$2,762.07
in general payments reported to CMS, 2019-2025
8 companies · $28.55 in 2025
The $28.55 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.56 · 2020: $57.46 · 2021: $1,941 · 2022: $49.66 · 2023: $565 · 2024: $41.68 · 2025: $28.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $437 · Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $437.37 |
| Food and Beverage | $197.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,539.00 | 2021-2023 | |
| Steelhead Surgical INC | $955.09 | 2021-2024 | |
| Avanos Medical | $164.53 | 2019-2025 | Genvisc 850 Sodium Hyaluronate, Trivisc Sodium Hyaluronate |
| Pacira Pharmaceuticals Incorporated | $31.45 | 2022-2023 | Iovera |
| Bioventus LLC | $21.76 | 2022 | |
| Djo, LLC | $19.92 | 2019 | |
| Abbott Laboratories | $15.24 | 2022 | |
| Depuy Synthes Sales INC. | $15.08 | 2025 | Orthovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Westerdahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.